In the BioHarmony Drug Report Database
Lariam, Mefloquine (mefloquine) is a small molecule pharmaceutical. Mefloquine was first approved as Lariam on 1989-05-02. It is used to treat falciparum malaria, malaria, and vivax malaria in the USA. It is known to target adenosine receptor A1, adenosine receptor A2a, and purine nucleoside phosphorylase.
Image (chem structure or protein)